Login / Register Order My Items
mob-logo
Contact Us
800.227.0627
Contact Us Quote Order Login / Register

PEGylation and PEG Modification Services

PEG-focused bioconjugation for improved solubility, stability, circulation time, and drug delivery performance.

activated PEG modifiers PEG size selection site-specific PEGylation PEGylated drugs & biologics PEG linker design
Request a Quote PEG Selection Guide
Talk to a chemist Request a quote
Overview What can be PEGylated PEG size & structure PEG modification chemistry PEG selection Technical guide Applications Related Recommended Reading FAQ Contact

Overview

PEGylation is the covalent attachment of polyethylene glycol (PEG) chains to biomolecules, therapeutic compounds, surfaces, or drug delivery carriers. Unlike a broad synthetic polymer conjugation page, this page focuses specifically on PEG size, PEG architecture, activated PEG chemistry, and PEG modification strategy.

Bio-Synthesis provides PEGylation and PEG modification services for drugs, small molecules, oligonucleotides, peptides, proteins, antibodies, and surfaces using activated PEG reagents, PEG size selection, site-specific chemistry, and custom PEG linker design.

  • Improve solubility of hydrophobic or aggregation-prone molecules.
  • Extend half-life by increasing hydrodynamic size and reducing rapid clearance.
  • Improve stability against proteolysis, aggregation, and formulation stress.
  • Enable delivery design through PEG linkers, PEG-lipids, cleavable PEG, and ligand-modified PEG systems.

PEG is one important class of synthetic polymer, but not all synthetic polymers are PEG. Other synthetic polymers include PLGA, PLA, PCL, PNIPAM, polyacrylates, poly(2-oxazoline), dendrimers, and stimuli-responsive polymers. PEGylation is best treated as a specialized service because PEG molecular weight, architecture, purity, dispersity, and reactive end-group chemistry strongly affect final conjugate performance.

PEGylation and PEG modification workflow showing PEG reagent selection, conjugation chemistry, purification, characterization, optimization, scale-up, and final product application
PEGylation and PEG modification workflow from strategy and PEG reagent selection to conjugation, purification, characterization, optimization, and final application.
Positioning note: Use this page for PEGylation and PEG modification. Use the broader synthetic polymer conjugation page for non-PEG polymers such as PLGA, PNIPAM, dendrimers, polyacrylates, and custom polymer scaffolds.

What Can Be PEGylated?

PEG modification can be applied to a wide range of biomolecules and delivery systems. Selection depends on functional groups, stability requirements, and delivery goals.

Drugs & Small Molecules

Improve solubility, reduce nonspecific binding, and enable prodrug or linker-based delivery strategies.

Explore PEGylated drugs →

Oligonucleotides

PEG acts as a spacer, solubility enhancer, or delivery component for siRNA, ASO, DNA, and RNA systems.

Explore oligo PEGylation →

Peptides

Reduce proteolysis and extend half-life while maintaining receptor binding via site-specific PEGylation.

Explore peptide PEGylation →

Proteins

Improve stability, reduce aggregation, and extend circulation time for enzymes and biologics.

Explore protein PEGylation →

Antibodies & Fragments

Modify mAb, Fab, scFv, and nanobodies to tune pharmacokinetics and reduce immunogenicity.

Explore antibody PEGylation →

Surfaces & Carriers

PEGylation reduces nonspecific binding and improves stability for nanoparticles, liposomes, and surfaces.

Explore surface PEGylation →

PEG Size, Structure, and Architecture

PEG molecular weight and architecture directly influence hydrodynamic radius, renal clearance, shielding, viscosity, activity retention, and purification. Selection should be application-driven rather than based on size alone.

PEG Format Common MW Range Architecture Why It Is Used Typical Molecules
Low MW PEG 200 Da-1k Da Linear / monodisperse Minimal steric effect; improves solubility and spacing. Small molecules, linkers, surfaces.
Mid MW PEG 2k-5k Da Linear / heterobifunctional Good balance of solubility, stability, and activity retention. Peptides, oligos, small proteins.
High MW PEG 10k-20k Da Linear or branched Extends circulation time and reduces rapid clearance. Proteins, enzymes, biologics.
Large PEG 30k-40k+ Da Linear or branched Strong shielding and half-life extension. Long-acting biologics, antibody fragments.
Branched PEG 5k-80k Da 2-arm / Y-shaped High steric protection with compact architecture. Proteins, peptides, antibody fragments.
Multi-arm PEG 10k-100k Da 4-arm / 6-arm / 8-arm Multivalent conjugation, hydrogels, and high-density functionalization. Hydrogels, biomaterials, surfaces.
Monodisperse PEG Defined discrete PEG units Uniform chain length Precise mass, easier characterization, and reproducible design. Oligos, peptides, regulated or analytical applications.
Heterobifunctional PEG 1k-20k Da Two different end groups Directional conjugation between two different molecules. Protein-drug, oligo-polymer, peptide-surface systems.
Homobifunctional PEG 1k-20k Da Same end groups Crosslinking, bridging, and hydrogel formation. Surfaces, biomaterials, crosslinked systems.
PEG-lipid / PEG-hydrophobic PEG 1k-5k Da Amphiphilic Membrane anchoring and colloidal stabilization. Liposomes, LNPs, micelles, nanoparticles.

For targeted delivery, PEG may be combined with ligands such as tri-GalNAc, peptides, antibodies, or small-molecule targeting groups. Tri-GalNAc is a targeting ligand system; PEG may be used as a spacer or linker component.

PEG Modification Chemistry by Target Functional Group

PEGylation chemistry is selected by matching the activated PEG reagent to the available functional group on the molecule, surface, or carrier.

Amine

NHS-PEG

Targets lysine residues or N-termini.

NHS-PEG → amide bond

Use: proteins, peptides, antibodies, amine-modified drugs.

Thiol

Maleimide-PEG

Targets cysteine or sulfhydryl groups.

Maleimide-PEG → thioether

Use: peptides, proteins, Fab fragments, nanobodies.

Click

DBCO / BCN-PEG

Targets azide-modified molecules using copper-free click chemistry.

DBCO-PEG + azide → triazole

Use: oligos, peptides, antibodies, polymers.

Carbonyl

Hydrazide / Aminooxy PEG

Targets aldehyde or ketone groups.

Hydrazide-PEG → hydrazone

Use: oxidized glycans, glycoproteins, carbonyl-bearing drugs.

Target Functional Group PEG Reagent Chemistry Type Typical Molecules Design Notes
Primary amine NHS-PEG / aldehyde-PEG Amide coupling or reductive amination Proteins, peptides, antibodies Efficient but may be heterogeneous unless N-terminal conditions are optimized.
Sulfhydryl / thiol Maleimide-PEG / iodoacetyl-PEG Thiol-selective coupling Peptides, proteins, antibody fragments Good for site-specific PEGylation when a unique cysteine is available.
Carboxyl Amine-PEG / hydrazide-PEG EDC/NHS coupling Proteins, peptides, polymers, small molecules Requires pH control and crosslinking risk management.
Aldehyde / ketone Hydrazide-PEG / aminooxy-PEG Hydrazone / oxime ligation Oxidized carbohydrates, glycoproteins, carbonyl-bearing drugs Useful for glyco-oriented conjugation and cleavable linker designs.
Azide DBCO-PEG / BCN-PEG SPAAC click chemistry Oligos, peptides, proteins, antibodies Highly selective and compatible with sensitive biomolecules.
Alkyne Azide-PEG CuAAC click chemistry Oligos, peptides, small molecules Orthogonal and efficient; copper compatibility must be reviewed.
Hydroxyl Activated carbonate PEG / tosyl-PEG Carbonate, ester, or ether formation Small molecules, polysaccharides, surfaces Less reactive; often requires activation or derivatization.
Surface groups Silane-PEG, thiol-PEG, PEG-lipid, reactive PEG Surface grafting or anchoring Nanoparticles, plates, beads, biosensors, liposomes Reduces nonspecific binding and improves biocompatibility or colloidal stability.

PEG Selection Decision Tree: Best PEG for Your Molecule

Selecting the right PEG requires balancing molecule type, available chemistry, PEG architecture, and delivery objective. The goal is to improve solubility, stability, half-life, or targeting while preserving binding, activity, uptake, and release.

PEG Selection Decision Tree showing molecule type, goal, PEG size, architecture, and chemistry selection workflow
PEG selection workflow: define molecule type and goal, then select PEG molecular weight, architecture, and reactive chemistry.
Molecule Type Typical PEG Size Preferred PEG Structure Common Chemistry Design Notes & Key Risk
Drug / Small Molecule 1k-5k Da Linear or cleavable PEG NHS, amine, hydrazide, click Focus on solubility, release behavior, and maintaining potency. Key risk: activity lossConsider cleavable PEG or spacer-based linker design when potency depends on target binding.
Peptide 2k-10k Da Linear, branched, or monodisperse PEG NHS, maleimide, click Balance protease resistance, half-life extension, and receptor binding. Key risk: reduced bindingUse site-specific PEGylation away from the pharmacophore or receptor-binding motif.
Protein 5k-20k Da Linear, branched, or site-specific PEG NHS, maleimide, aldehyde Improve stability and solubility while minimizing active-site interference. Key risk: active-site maskingPrefer site-directed PEGylation when structure-function relationships are known.
Antibody / Fragment 10k-40k Da Branched, site-specific, or heterobifunctional PEG Maleimide, click, NHS Preserve antigen binding while tuning circulation time and shielding. Key risk: steric hindranceTarget Fc, engineered cysteine, glycan, or non-CDR-accessible sites where possible.
Oligonucleotide 2k-10k Da Linear PEG, PEG-lipid, or ligand-modified PEG Click, amine, thiol, DBCO/BCN Useful for spacer design, solubility, stability, or carrier association. Key risk: delivery inefficiencyUse PEG as a spacer or combine with ligand-directed delivery such as GalNAc-based designs.
Surface / Nanoparticle 1k-10k Da PEG-lipid, silane-PEG, thiol-PEG, multi-arm PEG Surface grafting, click, thiol, silane Reduce nonspecific binding and improve colloidal stability. Key risk: poor coating stabilityUse anchored or covalent PEG when long-term surface retention is required.
Practical rule: choose the smallest PEG that achieves the desired solubility, stability, shielding, or pharmacokinetic improvement without blocking binding, activity, uptake, or release.

PEGylation Technical Guide

PEG modifiers are selected by balancing molecular weight, architecture, reactive group, linker stability, and the biological role of the final conjugate.

  • Low MW PEG: improves solubility with minimal steric impact.
  • High MW PEG: increases hydrodynamic radius and can reduce renal clearance.
  • Branched PEG: improves shielding without always requiring extremely long linear chains.
  • Monodisperse PEG: supports precise characterization and reproducible conjugate design.
  • Ligand-modified PEG: enables targeted delivery, such as tri-GalNAc PEG spacer designs for liver-targeted oligonucleotide systems.

PEG is used to improve aqueous solubility, reduce aggregation, extend circulation time, reduce nonspecific adsorption, and tune biodistribution. In drug delivery, PEG can be attached directly to the payload or incorporated into carriers such as liposomes, nanoparticles, hydrogels, and polymeric systems.

Uniform PEG modifiers have defined chain lengths and narrow molecular weight distribution. They are useful when exact mass, reproducible conjugation, and cleaner analytical characterization are important.

NHS-activated PEG reacts with primary amines such as lysine side chains or N-terminal amines. N-terminal PEGylation can improve product consistency compared with random lysine modification when reaction conditions are optimized.

Carboxyl groups can be activated with EDC/NHS chemistry and coupled to amine-functional PEG. This strategy is useful for carboxyl-containing proteins, peptides, polymers, and small molecules.

Maleimide-PEG and related thiol-reactive PEG reagents target cysteine or sulfhydryl groups. This approach is commonly used for site-specific PEGylation of peptides, proteins, antibody fragments, and engineered cysteine variants.

Hydroxyl PEGylation may require activated PEG derivatives, derivatization, or carbonate/ester formation. It is relevant for small molecules, polysaccharides, and surfaces but usually requires more careful chemistry than amine or thiol PEGylation.

Click PEGylation uses azide-alkyne chemistry or copper-free SPAAC with DBCO-PEG or BCN-PEG. It is widely used for oligonucleotides, peptides, proteins, antibodies, and orthogonal conjugation workflows.

Click PEGylation uses azide-alkyne chemistry or copper-free SPAAC with DBCO-PEG or BCN-PEG. It is widely used for oligonucleotides, peptides, proteins, antibodies, and orthogonal conjugation workflows.

Surface PEGylation reduces nonspecific binding and improves biocompatibility on nanoparticles, plates, beads, biosensors, membranes, and medical materials. Surface PEG can also tune colloidal stability and protein adsorption.

PEG can be incorporated into polymer backbones, grafted onto polymers, or used as a macroinitiator or crosslinking component to create hydrophilic, flexible, or responsive materials.

Reversible PEGylation uses cleavable linkers, such as pH-sensitive, redox-sensitive, enzyme-cleavable, or hydrolysable linkers, to provide shielding during delivery while allowing PEG removal after reaching the intended environment.

Homobifunctional PEG contains identical reactive groups at both ends, such as NHS-PEG-NHS or maleimide-PEG-maleimide. It is useful for crosslinking, bridging, hydrogel formation, and polymer network construction.

Heterobifunctional PEG contains two different reactive groups, such as NHS-PEG-maleimide or azide-PEG-DBCO. It enables directional conjugation between two different molecules, such as peptide-polymer, antibody-drug, oligo-polymer, or protein-surface systems.

Important: These groups overlap. A polymer can be synthetic, branched, biodegradable, and stimuli-responsive at the same time. Presenting them together as “systems and types” is appropriate for a service page as long as the internal grouping stays clear.

Applications of PEGylation

Drug Delivery

Improve solubility, circulation, shielding, and release behavior for PEGylated drugs and small molecules.

Protein Therapeutics

Extend half-life, reduce aggregation, and improve formulation behavior of enzymes, cytokines, and biologics.

Antibody & Fragment Systems

Modify Fab, scFv, nanobody, Fc, and antibody formats while controlling binding-site accessibility.

Oligonucleotide Delivery

Use PEG spacers, PEG-lipids, or ligand-directed PEG systems to tune stability and delivery of siRNA, ASO, DNA, or RNA.

Surface and Nanoparticle PEGylation

Reduce nonspecific adsorption and improve colloidal stability on particles, plates, beads, membranes, and biosensors.

Cleavable PEG Systems

Use pH-, enzyme-, redox-, or hydrolysis-sensitive PEG linkers for reversible shielding and controlled release.

FAQ

Is PEGylation the same as synthetic polymer conjugation?

No. PEGylation is one type of synthetic polymer conjugation focused on polyethylene glycol. Synthetic polymer conjugation is broader and includes PLGA, PNIPAM, polyacrylates, dendrimers, poly(2-oxazoline), and other polymers.

What is PEG modification?

PEG modification is the attachment of a PEG chain or PEG linker to a molecule, surface, or carrier using reactive PEG groups such as NHS, maleimide, DBCO, BCN, azide, alkyne, hydrazide, aldehyde, or amine.

What molecules can be PEGylated?

Common targets include drugs, small molecules, oligonucleotides, peptides, proteins, antibodies, antibody fragments, nanoparticles, surfaces, and delivery carriers.

How do I choose the right PEG size?

PEG size is selected based on molecule type and delivery goal. Smaller PEG often preserves activity, while larger or branched PEG improves shielding, hydrodynamic radius, and circulation time.

Which PEG is used for amine or thiol modification?

NHS-PEG is commonly used for amine modification, while maleimide-PEG is commonly used for thiol or cysteine modification.

What is the difference between homobifunctional and heterobifunctional PEG?

Homobifunctional PEG has identical reactive groups at both ends and is useful for crosslinking. Heterobifunctional PEG has two different reactive groups and is useful for directional conjugation between two different molecules.

More FAQ'sAll FAQ's

Contact & Quote Request

For the fastest review, send the molecule type, available functional groups, preferred PEG size or architecture, desired conjugation ratio, purity target, quantity, and intended application.

Fast quote checklist

  • Target molecule: drug, oligo, peptide, protein, antibody, or surface
  • Available groups: amine, thiol, carboxyl, azide, alkyne, aldehyde, hydroxyl
  • Preferred PEG: linear, branched, multi-arm, monodisperse, bifunctional, PEG-lipid
  • Desired linker: stable, cleavable, reversible, or site-specific
  • Quantity, purity, characterization, and documentation requirements

Fastest path

Request a Quote PEG Selection Guide

Recommended Reading & Bio-Synthesis Resources

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45+ years of delivering high quality, fast and scalable synthetic biology solutions.

Greetings Researchers,

Please be advised that any information, guidelines, writeups, and oral/video/graphic content on our website are intended solely as general guidelines.
It is the researcher's sole responsibility to conduct thorough research on the designs of the products intended for their experiments before submitting
their designs to Biosynthesis for review of production feasibility.
Thank you for your understanding.

Quick Links